Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yangzheng Xiaoji capsule for cancer-related fatigue
ChiCTR2100045512Phase 4Recruiting
- Sponsor
- Xi'an Jiaotong University Second Affiliated Hospital Department of Radiotherapy
- Start
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of yangzheng xiaoji capsule in Non-hematologic malignancy and cancer-related fatigue (CRF) (2 arms), sponsored by Xi'an Jiaotong University Second Affiliated Hospital Department of Radiotherapy. Primary endpoints: FACT-G scale and FACT-F scale. Started May 2021; status: recruiting.
02
Drugs
yangzheng xiaoji capsule
03
Conditions
Non-hematologic malignancycancer-related fatigue (CRF)
Beyond the preview
Go deeper on ChiCTR2100045512.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100045512.